Royal Fund Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Royal Fund Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-20	Closed	-$1K	–	631
2020 Q1	$1K	Hold	20	–	–	﹤0.01%	552
2019 Q4	$2K	Hold	20	–	–	﹤0.01%	559
2019 Q3	$2K	Hold	20	–	–	﹤0.01%	539
2019 Q2	$3K	Hold	20	–	–	﹤0.01%	482
2019 Q1	$3K	Buy	+20	New	+$2.98K	﹤0.01%	488

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Fund Management's GWPH Position: Q2 2020 in Review

Royal Fund Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2020, closing a stake of 20 shares — an estimated $1K sold.

Royal Fund Management first reported a position in GWPH in Q1 2019 and held it in 5 quarters. The position peaked at $3K in Q2 2019. 299 funds tracked by Wall St. Rank hold GWPH as of Q2 2020.

Royal Fund Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2020 after selling out during the quarter.
Royal Fund Management sold 20 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2020, an estimated $1K.
Royal Fund Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 5 quarters.
Royal Fund Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3K in Q2 2019.
299 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2020.

Based on Royal Fund Management's 13F filing for Q2 2020, filed 6 Aug 2020.